arsh (@neurojourney) 's Twitter Profile
arsh

@neurojourney

on a personal quest to catalogue future treatments for depression and anxiety

ID: 1015895109378850817

calendar_today08-07-2018 09:47:23

95 Tweet

30 Takipçi

632 Takip Edilen

arsh (@neurojourney) 's Twitter Profile Photo

Genuine question, there’s been so much research happening in neuroscience over the past few decades but are they not ‘clinically actionable’?

arsh (@neurojourney) 's Twitter Profile Photo

Being cautious has become a cool thing. Let's wait for large studies? Ya what those large studies on all those SSRI say? Think it's about time to listen to patients too not just studies

DIY tDCS (@diytdcs) 's Twitter Profile Photo

Magnetic Seizure Therapy or MST. A magnetic coil to the front part of the patient's head delivers a high-frequency pulse that induces a seizure. cbc.ca/news/health/de…

USBrainAlliance (@usbrainalliance) 's Twitter Profile Photo

This study by Flavio Frohlich PhD (The University of North Carolina at Chapel Hill), and funded in part by the BRAIN Initiative, shows 70% of 32 depression patients benefitted from tACS, setting stage for larger research study to follow.

arsh (@neurojourney) 's Twitter Profile Photo

Would anyone be interested in building a list of hope for anxiety and depression? Basically a list of drugs n treatments that could help people with anxiety and depression

Oskar Jefsen (@oskarjefsen) 's Twitter Profile Photo

Just uploaded my poster for European Psychiatric Association #EPA2019 on gene expression 👨‍🔬🧬🔬 in the rat 🐀 frontal cortex and hippocampus 🧠 in response to different doses of #psilocybin 💉🍄 See you in #Warsaw in a few weeks! 🇵🇱 doi.org/10.26226/morre…

Dr. Maddie Ray (@maddiehray) 's Twitter Profile Photo

I’m a PhD candidate studying neuroscience and I have depression. If you’re struggling, you’re not alone. It’s okay to not be okay 💚 #MentalHealthAwarenessWeek #MentalHealth #EndTheStigma

Dr. Liisa Galea (@liisagalea) 's Twitter Profile Photo

Here’s a radical idea: let’s redistribute some of the $B we spend on police to fund mental health (care/research). Mental health care should be part of our health care in 🇨🇦. With more attention paid to our mental health we’d have fewer people in crisis cbc.ca/news/canada/to…

Naheed Kurji (he/him) (@naheedkurji) 's Twitter Profile Photo

I’m thrilled to announce that Cyclica closed a $23M Series B round of financing. businesswire.com/news/home/2020… With these funds, we will decentralize the discovery of better medicines, and in doing so build the biotech pipeline of the future. Lear more at cyclicarx.com

Robin Carhart-Harris (@rcarhartharris) 's Twitter Profile Photo

Our next trial will be psilocybin therapy for anorexia. Ethics approval secured. Recruiting psychotherapy friendly clinicians with eating disorder expertise. DM me if you match.

Eddie Talks Drugs (@eddietalksdrugs) 's Twitter Profile Photo

Between confirmation of Ben Sessa's first UK clinics and @yesonip34's success getting their vision onto the November ballot, it's been quite an eventful month for psychedelic-assisted therapy!

Michael Pollan (@michaelpollan) 's Twitter Profile Photo

Yale is recruiting for study of psilocybin as a treatment for OCD: Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study. - Full Text View - ClinicalTrials.gov bit.ly/31FJFrY

Awakn™ Life Sciences (@awakn_ls) 's Twitter Profile Photo

"I’ve been a psychiatrist for 20yrs, I’ve never met a patient with depression/anxiety... I’ve met thousands of people with individual idiosyncratic clusters of issues… One of the things that interests me about psychedelics is getting away from a concept of categorical diagnoses”

Awakn™ Life Sciences (@awakn_ls) 's Twitter Profile Photo

"A comprehensive study with a 125 mg MDMA dose taken by 166 subjects in a clinical environment, showed 64% of the subjects gave reports that they found the controlled setting reassuring and it made them feel safe." Ben Sessa frontiersin.org/articles/10.33…

"A comprehensive study with a 125 mg MDMA dose taken by 166 subjects in a clinical environment, showed 64% of the subjects gave reports that they found the controlled setting reassuring and it made them feel safe." 
<a href="/BenSessa/">Ben Sessa</a>
 frontiersin.org/articles/10.33…